← FDA DRUG APPROVALS
FDA ANDA · ANDA217365
PALBOCICLIB CAPSULES
Sponsor: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
APPLICATION
ANDA217365
TYPE
ANDA
DOSAGE FORM
CAPSULE
MARKETING STATUS
None (Tentative Approval)
Products
PALBOCICLIB CAPSULESNone (Tentative Approval)
PALBOCICLIB 100MG · CAPSULE
PALBOCICLIB CAPSULESNone (Tentative Approval)
PALBOCICLIB 125MG · CAPSULE
Approval history
2025-11-13UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.